Dr. Reddy’s Laboratories Limited (NYSE:RDY) is one of the Best Indian Stocks to Buy for Next 5 Years. Dr. Reddy’s ...

Alvotech (NASDAQ:ALVO) is one of the best oversold NASDAQ stocks to buy now. On July 9, Alvotech (NASDAQ:ALVO) announced that ...

Alvotech (NASDAQ:ALVO) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts. On July 1, Alvotech (NASDAQ:ALVO) and Advanz Pharma announced a commercialization agreement to ...

Alvotech stock has dropped despite strong fundamentals and rapid sales growth. Read about ALVO's projected revenue, debt concerns, and tariff challenges.

REYKJAVIK, Iceland--(BUSINESS WIRE)--Alvotech Holdings S.A. (“Alvotech”), a global biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for ...

Alvotech has a commercialization partnership with Teva Pharmaceuticals TEVA in the United States. The brand names of AVT04 and AVT02 are Selarsdi and Simlandi, respectively, in the United States.

Alvotech and Advanz Pharma expand their European biosimilar partnership to include AVT10, targeting Cimzia® for rheumatic diseases.

Alvotech states that “STELARA is produced by using a mouse hybridoma (“Sp2/0”) host cell line, which allows for more efficient sialylation of the molecule as compared to, ...

On April 23, 2024, Alvotech announced “positive topline results from a confirmatory clinical study for AVT05,” Alvotech’s proposed golimumab biosimilar to Janssen Biotech, Inc.’s SIMPONI ...

Alvotech acquires Xbrane's R&D operations and biosimilar candidate XB003 for ~$27M, expanding into Sweden's life sciences sector. Xbrane retains key preclinical assets, strengthens finances, and ...

Here is how Alvotech (ALVO) and Becton Dickinson (BDX) have performed compared to their sector so far this year.

Alvotech asserts that its biosim is the first-filed copycat equal in strength to the latest version of Humira, which AbbVie markets as a high-concentration, pain-free version of the med.